Publications - Page 3 sur 43 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Pneumopathies interstitielles diffuses (PID)
COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study.

Papiris SA, Campo I, Mariani F, Kallieri M, Kolilekas L, Papaioannou AI, Gonca Chousein E, Cetinkaya E, Bonella F, Borie R, Kokosi M, Pickworth T, Molina-Molina M, Gasa M, Radzikowska E, Fijolek J, Jouneau S, Gomez E, McCarthy C, Bendstrup E, Piotrowski WJ, Pabary R, Hadchouel A, Coolen-Allou N, Alfaro T, Robalo Cordeiro C, Antonogiannaki EM, Tomos IP, Papakosta D, Kontakiotis T, Panagiotou P, Douros K, Schams A, Lettieri S, Papaevangelou V, Kanaka-Gantenbein C, Karakatsani A, Loukides S, Costabel U, Crestani B, Morgan C, Tazawa R, Bush A, Griese M, Manali ED.

ERJ Open Res. 2023 Jan 3;9(1):00199-2022.
Fibrose pulmonaire - FPI
Origins of pathological myofibroblasts in lung fibrosis: insights from lineage tracing mouse models in the single-cell RNA sequencing era

Homps-Legrand M, Crestani B, Mailleux AA.

Am J Physiol Lung Cell Mol Physiol. 2023 Jun 1;324(6):L737-L746.
Fibrose pulmonaire - FPI
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis.

Kolb M, Crestani B, Maher TM.

Eur Respir Rev. 2023 Feb 21;32(167):220206.
Transplantation pulmonaire
Outcome of lung transplantation for adults with interstitial lung disease associated with genetic disorders of the surfactant system

Bermudez J, Nathan N, Coiffard B, Roux A, Hirschi S, Degot T, Bunel V, Le Pavec J, Macey J, Le Borgne A, Legendre M, Cottin V, Thomas PA, Borie R, Reynaud-Gaubert M.

ERJ Open Res. 2023 Nov 20;9(6):00240-2023.
Pneumopathies interstitielles diffuses (PID)
Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors.

Sidali S, Borie R, de Fontbrune FS, El Husseini K, Rautou PE, Lainey E, Goria O, Crestani B, Cadrane J, Cottin V, Bune V, Dumortier J, Jacquemin E, Reboux N, Hirschi S, Bourdin A, Meszaros M, Dharancy S, Hilaire S, Mallet V, Reynaud-Gaubert M, Terriou L, Gottrand F, Abou Chahla W, Khan JE, Carrier P, Saliba F, Rubbia-Brandt L, Aubert JD, Elkrief L, de Lédinghen V, Abergel A, Olivier T, Houssel P, Jouneau S, Wemeau L, Bergeron A, Leblanc T, Ollivier-Hourmand I, Nguyen Khac E, Morisse-Pradier H, Ba I, Boileau C, Roudot-Thoraval F, Vilgrain V, Bureau C, Nunes H, Naccache JM, Durand F, Francoz C, Roulot D, Valla D, Paradis V, Kannengiesser C, Plessier A.

Hepatology. 2023 Nov 6.
Pneumopathies interstitielles diffuses (PID)
In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicentre study.

Chaigne B, Chevalier K, Boucly A, Agard C, Baudet A, Bourdin A, Chabanne C, Cottin V, Fesler P, Goupil F, Jego P, Launay D, Lévesque H, Maurac A, Mohamed S, Tromeur C, Rottat L, Sitbon O, Humbert M, Mouthon L.

Rheumatology (Oxford). 2023 Oct 3;62(10):3261-3267.
Pneumopathies interstitielles diffuses (PID)
Idiopathic pulmonary fibrosis with benign SFTPC variant and pathogenic MARS1 mutations: can’t see the forest for the trees!

Castaldo A, Delestrain C, Diesler R, Merveilleux du Vignaux C, Onnee M, Touraine R, Chalabreysse L, Fanen P, Epaud R, Cottin V, De Becdelièvre A.

ERJ Open Res. 2023 Nov 6;9(6):00472-2023.
Transplantation pulmonaire
Lung Transplantation under a Janus Kinase Inhibitor in Three Patients with SAVI Syndrome.

Berrada KR, Belot A, Neven B, Ohlmann C, Tronc F, Rice G, Thouvenin G, Dubus JC, Mazenq J, Frémond ML, Stremler N, Soummer-Feuillet S, Cottin V, Reix P.

J Clin Immunol. 2023 Nov;43(8):2156-2164.
Pneumopathies interstitielles diffuses (PID)
Leukocyte telomere length: the dawn of a new era of personalised medicine in fibrotic interstitial lung diseases?

Cottin V, Kolb M.

Eur Respir J. 2023 Nov 29;62(5):2301852.
Pneumopathies interstitielles diffuses (PID)
Imaging Features of Autoimmune Disease-Related Interstitial Lung Diseases

Walsh SLF, Lafyatis RA, Cottin V.

J Thorac Imaging. 2023 Nov 1;38(Suppl 1):S30-S37.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study.

Origins of pathological myofibroblasts in lung fibrosis: insights from lineage tracing mouse models in the single-cell RNA sequencing era

Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis.

Outcome of lung transplantation for adults with interstitial lung disease associated with genetic disorders of the surfactant system

Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors.

In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicentre study.

Idiopathic pulmonary fibrosis with benign SFTPC variant and pathogenic MARS1 mutations: can’t see the forest for the trees!

Lung Transplantation under a Janus Kinase Inhibitor in Three Patients with SAVI Syndrome.

Leukocyte telomere length: the dawn of a new era of personalised medicine in fibrotic interstitial lung diseases?

Imaging Features of Autoimmune Disease-Related Interstitial Lung Diseases